The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
- PMID: 2537532
- DOI: 10.1126/science.2537532
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
Abstract
Deletions or mutations of the retinoblastoma gene, RB1, are common features of many tumors and tumor cell lines. Recently, the RB1 gene product, p105-RB, has been shown to form stable protein/protein complexes with the oncoproteins of two DNA tumor viruses, the adenovirus E1A proteins and the simian virus 40 (SV40) large T antigen. Neither of these viruses is thought to be associated with human cancer, but they can cause tumors in rodents. Binding between the RB anti-oncoprotein and the adenovirus or SV40 oncoprotein can be recapitulated in vitro with coimmunoprecipitation mixing assays. These assays have been used to demonstrate that the E7 oncoprotein of the human papilloma virus type-16 can form similar complexes with p105-RB. Human papilloma virus-16 is found associated with approximately 50 percent of cervical carcinomas. These results suggest that these three DNA viruses may utilize similar mechanisms in transformation and implicate RB binding as a possible step in human papilloma virus-associated carcinogenesis.
Similar articles
-
Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.Proc Natl Acad Sci U S A. 1992 May 15;89(10):4549-53. doi: 10.1073/pnas.89.10.4549. Proc Natl Acad Sci U S A. 1992. PMID: 1316611 Free PMC article.
-
Point mutational inactivation of the retinoblastoma antioncogene.Science. 1989 Feb 17;243(4893):937-40. doi: 10.1126/science.2521957. Science. 1989. PMID: 2521957
-
The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations.EMBO J. 1990 Apr;9(4):1147-55. doi: 10.1002/j.1460-2075.1990.tb08221.x. EMBO J. 1990. PMID: 2138977 Free PMC article.
-
Interactions of SV40 large T antigen and other viral proteins with retinoblastoma tumour suppressor.Rev Med Virol. 2002 Mar-Apr;12(2):81-92. doi: 10.1002/rmv.340. Rev Med Virol. 2002. PMID: 11921304 Review.
-
Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.Princess Takamatsu Symp. 1991;22:239-48. Princess Takamatsu Symp. 1991. PMID: 1668886 Review.
Cited by
-
Isolation of three novel rat and mouse papillomaviruses and their genomic characterization.PLoS One. 2012;7(10):e47164. doi: 10.1371/journal.pone.0047164. Epub 2012 Oct 15. PLoS One. 2012. PMID: 23077564 Free PMC article.
-
Association of human papillomavirus 16 and 18 with ovarian cancer risk: Insights from a meta‑analysis.Oncol Lett. 2024 Sep 19;28(6):556. doi: 10.3892/ol.2024.14689. eCollection 2024 Dec. Oncol Lett. 2024. PMID: 39355783 Free PMC article.
-
Transoral Robotic Surgery and Human Papillomavirus Infection: Impact on Oropharyngeal Cancer Prognosis.J Clin Med. 2024 Jul 30;13(15):4455. doi: 10.3390/jcm13154455. J Clin Med. 2024. PMID: 39124727 Free PMC article.
-
E7 oncoprotein from human papillomavirus 16 alters claudins expression and the sealing of epithelial tight junctions.Int J Oncol. 2020 Oct;57(4):905-924. doi: 10.3892/ijo.2020.5105. Epub 2020 Jul 29. Int J Oncol. 2020. PMID: 32945372 Free PMC article.
-
Abundance and state of phosphorylation of the retinoblastoma susceptibility gene product in human colon cancer.Mol Cell Biochem. 1992 Mar 25;110(2):123-33. doi: 10.1007/BF02454189. Mol Cell Biochem. 1992. PMID: 1584201
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous